Mesenchymal stem cells overexpressing Sirt1 inhibit prostate cancer growth by recruiting natural killer cells and macrophages-Reference-Cited by-同舟云学术

Mesenchymal stem cells overexpressing Sirt1 inhibit prostate cancer growth by recruiting natural killer cells and macrophages

Published:2016-10-18 Issue:44 Volume:7 Page:71112-71122
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Yu Yang¹,Zhang Qingyun¹,Meng Qinggui¹,Zong Chen²,Liang Lei²,Yang Xue²,Lin Rui¹,Liu Yan³,Zhou Yang¹,Zhang Hongxiang¹,Hou Xiaojuan²,Han Zhipeng²,Cheng Jiwen¹

Affiliation:

1. Department of Urology, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, People's Republic of China

2. Tumor Immunology and Gene Therapy Center, Eastern Hepatobiliary Surgery Hospital, The Second Military Medical University, Shanghai, People's Republic of China

3. The Fifth Department of Chemotherapy, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, People's Republic of China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mesenchymal stem cells and their extracellular vesicles in urological cancers: Prostate, bladder, and kidney;Cell Biology International;2023-11-10

2. The Role of Mesenchymal Stem Cells in Cancer Immunotherapy;Current Stem Cell Research & Therapy;2023-11

3. Mesenchymal stem cells and prostate cancer: A concise review of therapeutic potentials and biological aspects;Stem Cell Research;2022-08

4. Mesenchymal stem cells-based therapy in liver diseases;Molecular Biomedicine;2022-07-27

5. Genetically-modified Stem Cell in Regenerative Medicine and Cancer Therapy; A New Era;Current Gene Therapy;2022-02